Thiabendazole (TBZ) is a broad-spectrum antihelmintic used for treatment of parasitic infections in animals and humans and as an agricultural fungicide for post-harvest treatment of fruits and vegetables. It is teratogenic and nephrotoxic in mice, and cases of hepatotoxicity have been observed in humans.
Introduction
Thiabendazole (TBZ) (Fig. 1) is a broad-spectrum antihelmintic used for treatment of parasitic infections in animals and humans and an agricultural fungicide for post-harvest treatment of fruits and vegetables (Groten et al., 2000; Walton et al., 1999) . It is recognized as a potent nephrotoxin which causes tubular necrosis leading to severe kidney damage, and a teratogen which results in impairment of mouse limb development and selective toxicity to the embryo Tada et al., 1992; Fujitani et al., 1999; Ogata et al., 1984; Mizutani et al., 1990) . Irreversible binding of TBZ-related radioactivity to macromolecules and tissue protein in the mouse embryo has also been observed following oral dosing of [
14 C]TBZ to pregnant mice (Yoneyama and Ichikawa, 1986) . In humans, several isolated cases of hepatotoxicity such as intrahepatic cholestasis or micronodular cirrhosis have also been reported following TBZ administration (Manivel et al., 1987; Bion et al., 1995) . It is currently believed that TBZ-induced nephrotoxicity is a result of P450-dependent oxidative cleavage of the thiazole moiety in TBZ to a proximate toxicant, thioformamide ( Fig. 1 ) (Mizutani et al., 1994) . However, mechanisms responsible for TBZ-induced hepatotoxicity in humans and teratogenicity in preclinical species are not clear.
TBZ is extensively metabolized in animals and humans (Tocco et al., 1966) . The primary route of metabolism is the CYP1A2-catalyzed formation of 5-hydroxythiabendazole (5-OHTBZ), which is further converted to a glucuronide and a sulfate conjugate and is eliminated in the urine and bile (Coulet et al., 1998a; Rey-Grobellet et al., 1996; Coulet et al., 1998b; Wilson et al., 1973) .
Other metabolites such as 4-hydroxythiabendazole, 2-acetylbenzimidazole, N-treatment of CYP1A2-expressing liver cells with isolated [ 14 C]5-OHTBZ leads to significant covalent binding of the radiolabel (Coulet et al., 2000) . Furthermore, 5-OHTBZ has been described to possess the same teratogenic potential as the parent drug, TBZ, as demonstrated in a limb bud culture system (Tsuchiya et al., 1987) . A possible link between 5-OHTBZ and hepatic injury has also been established based on the relationship between systemic peak concentrations of 5-OHTBZ and the onset of TBZ toxicity (Coulet et al., 1998b ). All the above reports suggest that TBZ-induced toxicity can also be exerted via bioactivation of its major metabolite, 5-OHTBZ.
Although several mechanisms for the metabolic activation of 5-OHTBZ and its adduct formation have been proposed, the chemical structure of the reactive species has not been identified (Coulet et al., 2000) . Structural similarities between the 5-hydroxybenzimidazole portion of TBZ and p-amino substituted phenolic compounds such as acetaminophen ( Fig. 1) suggests that 5-OHTBZ can undergo metabolic activation to quinone imine like species via oxidation by enzyme systems such as P450 or peroxidases such as, prostaglandin H synthase (PGS). para-Amino substituted phenols are known to undergo bioactivation to electrophilic quinone imines by these oxidative enzyme systems and covalently bind to cellular thiols or be scavenged by reduced GSH (Monks and Jones 2002; Potter and Hinson 1987a; Moldéus et al., 1982) . The objective of the current study was to examine the ability of 5-OHTBZ to undergo oxidative bioactivation by these enzyme systems and structurally characterize the resulting reactive species by trapping with glutathione.
This article has not been copyedited and formatted. The final version may differ from this version. Isopropylester of glutathione (GSH-IP) was obtained from Bachem (Torrance, CA). Human liver microsomes were prepared from human livers (International Institute for the Advancement of Medicine, Jessup, PA) using standard protocols and were characterized using P450-specific marker substrate activities. Aliquots from the individual preparations from 56 individual human livers were pooled on the basis of equivalent protein concentrations to yield a representative microsomal pool with a protein concentration of 20.4 mg/mL (determined using the Bicinchoninic Acid Assay; Pierce, Rockford, IL). Individual recombinant CYP1A2 co-expressed with NADPH-P450 oxidoreductase in baculovirus-infected insect cells were obtained from Panvera Corp.
(Madison, WI). The protein concentration of the recombinant enzyme was 10.4 mg/mL and P450 content was 1.1 nmol/mL. Mouse liver and β-napthoflavone-treated rat liver microsomes (protein concentration, 20 mg/mL) were obtained from Xenotech LLC (Kansas City, KS). Other chemicals and reagents were of the highest quality available.
Microsomal Incubations of TBZ. The microsomal metabolism of TBZ was studied using liver microsomal preparations from human and mouse. Incubations (total volume 1.0 mL) were carried out at 37 °C for 60 min and contained 10 mM magnesium chloride, microsomal protein (2.0 mg/mL) or recombinant CYP1A2 (1 mg/mL), TBZ (50 µM) and 2.4 mM NADPH (prepared fresh) in 100 mM potassium phosphate buffer (pH 7.4). The TBZ stock solution was prepared in DMSO. The final concentration of DMSO in the incubation media was <0.2%. For detection of GSH conjugates, the incubations were fortified with reduced GSH (2 mM). Incubations that lacked NADPH, GSH or microsomes served as negative controls. All reactions were terminated Generation of the 5-OHTBZ Metabolite. 5-OHTBZ was generated by microsomal incubation of TBZ using the experimental conditions described above except that β-napthoflavone-treated rat liver microsomes (protein concentration 2 mg/mL) were used in the incubation mixture. After 45 min of incubation, additional NADPH (2 mM) was added to the incubation mixture to drive the reaction to completion. The reaction was stopped by addition of with ethyl acetate (3 mL) after 90 min and vortexed for 10 min. The mixture was then centrifuged and the ethyl acetate layer was separated and evaporated to dryness under a stream of N 2 . The residue was reconstituted in mobile phase and analyzed by HPLC/MS to ensure the formation of 5-OHTBZ. The molecular ion and the retention time of the metabolite was compared to that of the authentic 5-OHTBZ (Dr. Ehrenstorfer GmBH, Augsburg, Germany) for confirming the formation of the metabolite. This crude 5-OHTBZ was used without further purification in subsequent liver microsomal or peroxidase incubations. A freshly prepared 5-OHTBZ sample was used for each of the incubations discussed below. An assessment of the yield of extracted 5-OHTBZ metabolite was made by comparing the peak area of the extracted material with that of the authentic 5-OHTBZ reference standard at 318 nm in the UV chromatogram and was estimated to be ~30% (15.4 nmol/mL).
Microsomal Incubation of 5-OHTBZ Metabolite. Dried ethyl acetate extract of the TBZ incubation (described above) containing 5-OHTBZ was reconstituted in a mixture containing phosphate buffer (100 mM, pH 7.4), MgCl 2 (10 mM), human or mouse liver microsomes (1 mg/mL), reduced GSH (2 mM) and NADPH (2 mM) in a final volume of 1.0 mL. After 60 min of incubation at 37 °C, the mixture was processed as described previously and 75 µL aliquot of the reconstituted residue was analyzed by LC-MS/MS for the detection of GSH conjugate (M3).
Incubations of 5-OHTBZ with HRP. 5-OHTBZ was prepared as described above and resulting ethyl acetate extract was dried and reconstituted in a mixture containing phosphate buffer (100 mM, pH 7.4), HRP (2 units/mL), reduced GSH and/or reduced GSH-IP (5 mM) in a final volume of 1 mL. The reaction was initiated by addition of H 2 O 2 (500 µM) and terminated after 30 min of incubation at 37 °C by addition of ascorbic acid solution (2 mM) followed by acetonitrile (5 mL) . range of m/z 125-1000. For a full scan, the automatic gain control was set at 5.0 x 10 8 , maximum ion time was 100 ms and the number of microscans was set at 3. For MS n scanning, the automatic gain control 1.0 x 10 8 , maximum ion time was 400 ms and the number of microscans was set at 2. For data dependent scanning, the default charge-state was 1, default isolation width was 3.0, normalized collision energy was 45.0.
Isolation of GSH-IP conjugate (M5) and 1 H NMR Analysis. GSH-IP conjugate (M5) was generated using HRP by the method described above and separated by HPLC on an Aqua C18 column (5 um, 150 x 4.6 mm, Phenomenex, Torrance CA). The product was eluted using a linear gradient starting with acetonitrile at 10% and 0.1% formic acid (90%) and ramped to 70% acetonitrile over 20 minutes at a flow rate of 1 mL/min. Fractions were collected every 30 seconds throughout the run. The pooled fractions were evaporated to dryness, reconstituted in mobile phase and again subjected to HPLC separation using the same column but under to examine its purity. 1 H and 2D COSY NMR spectra were recorded at 30 °C on a 700 MHz Bruker-Biospin AV700 spectrometer equipped with a 5 mm TCI z-gradient Cryoprobe. 1 H NMR data were acquired with water suppression using a Watergate W5 pulse sequence with gradients and a double echo.
1 H 1 H COSY NMR data were acquired without solvent suppression using gradient pulses for coherence selection. Data processing was performed using the XWINNMR 3.5 software package (Bruker-Biospin). Chemical shifts were referenced to an internal standard of tetramethylsilane.
This article has not been copyedited and formatted. The final version may differ from this version. (Table 1 ). The new pattern showed two doublets (J = 9.0 Hz) at 7.5 and 6.83 ppm, which was assigned to the protons c and d at positions 6 and 7 and a doublet at 7.3 ppm that was assigned to the proton f at position
The identity of 5-OHTBZ was further confirmed by comparison of its MS spectra and
This article has not been copyedited and formatted. The final version may differ from this version. retention time to that of the authentic 5-OHTBZ. The minor peak, DiOHTBZ, on the other hand gave fragment ions that were consistent with dihydroxylated thiabendazole (data not shown).
Formation of GSH Conjugate of 5-OHTBZ (M3) by Human and Mouse Liver Microsomes.
LC/MS/MS analysis of NADPH-supplemented human or mouse liver microsomal and recombinant CYP1A2 incubations containing TBZ and reduced GSH afforded only one adduct (M3) (R t = ~20 min) with a molecular ion (MH + ) at 523 (Fig. 4A ). All incubations produced the same adduct as observed from its retention time and the molecular weight. The product ion mass spectrum of M3 produced fragment ions at m/z 505, 394 and 250 (Fig. 4B) . The fragment ion m/z 394 indicated a loss of 129 amu from the molecule and corresponded to loss of the pyroglutamate moiety, which is characteristic of a glutathione conjugate (Baillie and Davis, 1993) . The fragment ion at m/z 250 was assigned as a cleavage adjacent to cysteinyl thioether moiety with the charge retention on the hydroxythiabendazole moiety (Fig. 4B ).
Incubation of 5-OHTBZ with human or mouse liver microsomes and recombinant CYP1A2
containing NADPH and reduced GSH, also afforded the same GSH conjugate as that produced in the incubations with TBZ (data not shown). Although the synthetic standard of 5-OHTBZ was available, it was expensive and very difficult to obtain. Therefore, 5-OHTBZ was generated by incubation of TBZ with hepatic microsomes in this study. The formation of 5-OHTBZ is mainly catalyzed by CYP1A2 (Coulet et al., 1998b) therefore, β-napthoflavone treated rat liver microsomes were used to produce this metabolite from TBZ as described in the methods section. This procedure yielded about 30% of the 5-OHTBZ (after extraction with ethyl acetate).
The total ion chromatogram and the UV chromatogram of the extracted material showed only one peak suggesting that the extracts were free of unreacted TBZ. Further, the molecular ion and the retention time of this peak coincided with the retention time and the molecular ion of the authentic standard of 5-OHTBZ further confirming the structure of the metabolite. Since the focus of this study was to identify the glutathione conjugate of 5-OHTBZ, extracted 5-OHTBZ In addition to M3, HRP-mediated incubations also resulted in another product (M4) that gave a protonated molecular ion of m/z 433 in the LC/MS analysis (Fig. 5B) . The product ion of m/z 433 produced fragment ions at m/z 406, 218 and 191 (Fig. 5C ). The fragment ion at m/z 406 indicated a loss of 27 amu, which was similar to that observed in the product ion spectra of TBZ and 5-OHTBZ (Fig. 3) . The major ion at m/z 218 and 191 suggested a cleavage of M4 to the 5-OHTBZ moiety and a subsequent loss of 27 amu as observed before (Fig. 3) . Together, this data suggested that M4 was a dimer of 5-OHTBZ. carboxylic acid analog. This was consistent with previous reports by Soglia (Soglia et al., 2004) that showed a similar increase in sensitivity on using an ethyl ester of reduced GSH.
Formation and Structural Characterization of GSH-IP conjugate of 5-OHTBZ (M5) Using
Incubations of 5-OHTBZ with the HRP/H 2 O 2 system and containing GSH-IP gave the corresponding GSH-IP conjugate, M5, with a retention time of 25 min (Fig. 6A) . LC-MS/MS analysis of M5 gave a molecular ion at m/z 565, which was 42 amu greater than the molecular ion of M3 (m/z 523). The MS/MS spectrum of M5 gave fragment ions at m/z 436 and 250 (Fig.   6B ). The ion at m/z 436 was 42 amu greater than m/z 394 and the ion at m/z 250 was similar to that observed in MS/MS spectrum of M3 (Fig. 4B ).
Repurified M5 was found to be free of detectable unreacted GSH-IP and suitable for NMR experiments. 1 H NMR and 1 H 1 H COSY experiments were performed by dissolving M5 in deuterated methanol and allowed confirmation of the structure of GSH-IP adduct. The key change in the 1 H NMR spectrum of M5 was the disappearance of the resonance signal at 7.3 ppm for proton f at the 4-position of 5-OHTBZ (Table 1) Two additional peaks (M6/M7, R t = 27.2 and 28 min) with protonated molecular ion at m/z 912 were also detected in the total ion chromatogram when 5-OHTBZ was incubated with HRP, H 2 O 2 , and reduced GSH-IP (Fig. 7A) . The MS/MS spectra of both peaks at m/z 912 were similar and showed major fragment ions at m/z 783 and 654 corresponding to losses of one and two pyroglutamate moieties, respectively (Fig. 7B ). This suggested that the products were GSH-IP adducts of 5-OHTBZ in which two molecules of reduced GSH-IP were added to one 
Discussion
The potential of 5-OHTBZ, a major metabolite of TBZ, to undergo metabolic activation by P450
and peroxidases was explored in this study. In vitro conjugation with glutathione is a commonly used model to establish the presence of reactive metabolites and probe metabolic activation.
This method was used to trap the reactive metabolites of 5-OHTBZ in the current study.
Identification of the GSH conjugate of 5-OHTBZ (M3) in incubations of TBZ with NADPH and GSH supplemented hepatic microsomes or recombinant CYP1A2, clearly indicated an alternative P450-catalyzed mechanism of bioactivation of TBZ in addition to the previously reported thiazole cleavage mechanism. Although the precise mechanism was not definitively established, the absence of other GSH conjugates in the incubation mixtures suggested that M3
was formed by P450-catalyzed 2-electron oxidation of 5-OHTBZ followed by nucleophilic attack of reduced GSH on the resulting quinone imine 1 (Scheme 1). This was further confirmed when incubations of isolated 5-OHTBZ with NADPH and GSH supplemented liver microsomes afforded the same GSH adduct M3, as observed in TBZ supplemented incubations. Twoelectron oxidation of phenols by P450 has been previously documented (Testa, 1995) .
Previous studies on P450-mediated acetaminophen bioactivation have also suggested a similar mechanism for acetaminophen conversion to N-acetyl-p-benzoquinone imine (Potter and
Hinson, 1987a). Attempts to isolate or characterize the quinone imine intermediate of 5-OHTBZ
by LC-MS/MS failed and this was attributed to its instability.
Incubations of 5-OHTBZ with HRP or microsomal PGS also produced M3 when GSH was present in the media. This suggested that 5-OHTBZ was also metabolized by peroxidases.
Furthermore, the presence of M3 in RSV microsomal incubations containing H 2 O 2 indicated that hydroperoxidase activity of PGS catalyzes this oxidation. HRP is a non-specific one-electron oxidant that is widely used in analogous studies of oxidative bioactivation of endogenous and Thompson et al., 1989) . A mechanism similar to that described for the oxidation of acetaminophen by HRP and PGS was therefore proposed for the oxidation of 5-OHTBZ and is shown in Scheme 2. The peroxidase-catalyzed one electron oxidation of 5-OHTBZ would produce a phenoxy radical (2). This radical could rearrange to the corresponding carbon centered phenyl radical 3 that could dimerize to M4. Alternatively, a disproportionation reaction between two molecules of 3 or a sequential peroxidase-mediated single electron oxidation of 2 (Bessems et al., 1998) can afford the quinone imine like species (1), which on reaction with GSH or GSH-IP can afford M3 or M5, respectively. Since the identity of GSH conjugate formed by P450 and peroxidase was the same (based on the retention time and MS/MS spectra), it was reasonable to assume that 5-OHTBZ was activated to the same reactive intermediate by both enzyme systems.
This article has not been copyedited and formatted. The final version may differ from this version. As mentioned before, GSH-IP was used for further characterization of the GSH adduct, M5, by NMR. Since GSH-IP was only an isopropyl derivative of reduced GSH, it was conceivable that the site of attack by reduced GSH to form M3 would be the same as in M5. Although three sites were available in 1 for nucleophilic attack by GSH, actual structural assignment by NMR suggested the addition of GSH-IP at the 4-position of 5-OHTBZ. This was probably due to extended charge delocalization in the intermediate and greater electronegativity of oxygen relative to that of nitrogen. Furthermore, the attack at the 4 position of 1 was probably attributed to greater electrophilicity of the C4 position, which is flanked by the carbonyal group and an electronegative sp 2 nitrogen (imine functionality of benzimidazole) compared to position 6.
A bis-conjugate (M6/M7), in which two molecules of GSH-IP were added to 5-OHTBZ, was also detected in the peroxidase-mediated incubations (Scheme 2). Previous studies have demonstrated that introduction of cysteinyl groups into the molecule decreases its redox potential and these molecules undergo redox cycling to produce reactive oxygen species more readily than quinone imines (Lindqvist et al., 1991) . A similar conclusion could be made in this study. Thus, formation of M5 made it even more prone to oxidation and susceptible to a nucleophilic attack by second GSH-IP molecule. It is possible that this potential of the GSH conjugate to readily oxidize can increase, rather than decrease, the toxic effects of quinone imines by stressing the endogenous thiol pool and depleting cellular GSH. Since the bisconjugate was formed in smaller amounts, no attempt was made to isolate and characterize it.
Hence the exact position of addition of the second GSH-IP group could not be determined.
In conclusion, this study provides evidence that 5-OHTBZ can undergo oxidation by P450 and peroxidases to an electrophilic species that can be trapped by GSH. The results also support the role of 5-OHTBZ in the toxicity of TBZ that have been previously postulated by Coulet and co-workers (Coulet et al., 2000) . The reaction of activated 5-OHTBZ with thiols could be of biological significance especially since TBZ administration has been shown to increase the depletion of renal and hepatic GSH in vivo (Mizutani et al., 1990) . Although the in vivo relevance of 5-OHTBZ activation by peroxidases and/or P450 and the GSH conjugate formation is not established in this study, the results provide some indication that TBZ-induced toxicities observed in animals and humans could partially be due to peroxidase and/or P450-mediated bioactivation of 5-OHTBZ, in addition to the well-documented thiazole cleavage.
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